Continuing increased risk of second cancer in long‐term testicular cancer survivors after treatment in the cisplatin era

R Hellesnes, Ø Kvammen, TÅ Myklebust… - … journal of cancer, 2020 - Wiley Online Library
Using complete information on total treatment burden, this population‐based study aimed to
investigate second cancer (SC) risk in testicular cancer survivors (TCS) treated in the …
被引用次数：51 相关文章

Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era

R Hellesnes, Ø Kvammen… - … journal of cancer, 2020 - pubmed.ncbi.nlm.nih.gov
Using complete information on total treatment burden, this population-based study aimed to
investigate second cancer (SC) risk in testicular cancer survivors (TCS) treated in the …

Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era

R Hellesnes, Ø Kvammen, TÅ Myklebust… - International Journal of …, 2020 - duo.uio.no
Using complete information on total treatment burden, this population‐based study aimed to
investigate second cancer (SC) risk in testicular cancer survivors (TCS) treated in the …

Continuing increased risk of second cancer in long‐term testicular cancer survivors after treatment in the cisplatin era

R Hellesnes, Ø Kvammen, TÅ Myklebust… - International Journal of …, 2020 - infona.pl
Using complete information on total treatment burden, this population‐based study aimed to
investigate second cancer (SC) risk in testicular cancer survivors (TCS) treated in the …

Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era

R Hellesnes, Ø Kvammen, TÅ Myklebust, RM Bremnes… - 2019 - ntnuopen.ntnu.no
Using complete information on total treatment burden, this population‐based study aimed to
investigate second cancer (SC) risk in testicular cancer survivors (TCS) treated in the …

Continuing increased risk of second cancer in long‐term testicular cancer survivors after treatment in the cisplatin era.

R Hellesnes, Ø Kvammen… - … Journal of Cancer, 2020 - search.ebscohost.com
Using complete information on total treatment burden, this population‐based study aimed to
investigate second cancer (SC) risk in testicular cancer survivors (TCS) treated in the …

Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.

R Hellesnes, Ø Kvammen, TÅ Myklebust… - … Journal of Cancer, 2019 - europepmc.org
Using complete information on total treatment burden, this population-based study aimed to
investigate second cancer (SC) risk in testicular cancer survivors (TCS) treated in the …

Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era

R Hellesnes, Ø Kvammen, TÅ Myklebust… - Hellesnes, R.(2021) …, 2019 - munin.uit.no
Using complete information on total treatment burden, this population‐based study aimed to
investigate second cancer (SC) risk in testicular cancer survivors (TCS) treated in the …